BHVN

17.20

1.09% -0.19

Handel nachbörslich: 17.54 0.34 +1.98%

Biohaven Ltd (BHVN)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BHVN? Forum Prognose

Schlusskurs vom Vortag:

$17.39

Offen:

$17.2

24-Stunden-Volumen:

2.43M

Relative Volume:

1.09

Marktkapitalisierung:

$1.82B

Einnahmen:

Nettoeinkommen (Verlust:

$-766.97M

KGV:

-2.2454

EPS:

-7.66

Netto-Cashflow:

$-646.43M

1W Leistung:

+3.61%

1M Leistung:

+14.59%

6M Leistung:

-22.24%

1J Leistung:

-65.43%

1-Tages-Spanne:

$16.90

$17.84

1-Wochen-Bereich:

$16.80

$18.57

52-Wochen-Spanne:

$12.79

$54.98

Biohaven Ltd Stock (BHVN) Company Profile

Firmenname

Biohaven Ltd

Sektor

Healthcare (1135)

Branche

Biotechnology (635)

Telefon

203-404-0410

Adresse

215 CHURCH STREET, NEW HAVEN, CT

Mitarbeiter

256

Twitter

@biohavenpharma

Nächster Verdiensttermin

2025-08-08

Neueste SEC-Einreichungen

BHVN's Discussions on Twitter

Vergleichen Sie BHVN mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BHVN Biohaven Ltd	17.20	1.84B	0	-766.97M	-646.43M	-7.66
VRTX Vertex Pharmaceuticals Inc	425.57	107.66B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	651.80	68.74B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	456.04	58.93B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	818.50	50.51B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.60	41.29B	447.02M	-1.18B	-868.57M	-6.1812

Biohaven Ltd Stock (BHVN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-09-17	Eingeleitet	Citigroup	Buy
2025-09-03	Eingeleitet	Raymond James	Strong Buy
2025-05-19	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2025-02-11	Eingeleitet	Deutsche Bank	Buy
2024-09-16	Eingeleitet	Jefferies	Buy
2024-09-04	Eingeleitet	Bernstein	Outperform
2024-07-24	Eingeleitet	Morgan Stanley	Overweight
2024-02-16	Eingeleitet	RBC Capital Mkts	Outperform
2024-02-06	Eingeleitet	UBS	Buy
2023-12-22	Eingeleitet	H.C. Wainwright	Buy
2023-12-08	Eingeleitet	Robert W. Baird	Outperform
2023-01-24	Eingeleitet	SVB Securities	Outperform
2023-01-04	Eingeleitet	JP Morgan	Overweight
2022-12-02	Eingeleitet	BTIG Research	Buy
2022-10-26	Hochstufung	Cantor Fitzgerald	Neutral → Overweight
2022-10-12	Eingeleitet	Piper Sandler	Overweight
2022-08-19	Herabstufung	Piper Sandler	Overweight → Neutral
2022-08-08	Herabstufung	Wedbush	Outperform → Neutral
2022-05-11	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2021-10-19	Fortgesetzt	Morgan Stanley	Equal-Weight
2021-08-10	Herabstufung	UBS	Buy → Neutral
2021-08-03	Bestätigt	Canaccord Genuity	Buy
2021-03-11	Eingeleitet	UBS	Buy
2020-12-15	Eingeleitet	H.C. Wainwright	Buy
2020-04-17	Eingeleitet	Cowen	Outperform
2020-02-10	Herabstufung	Oppenheimer	Outperform → Perform
2020-02-06	Eingeleitet	Mizuho	Buy
2019-11-22	Eingeleitet	Wedbush	Outperform
2019-06-25	Bestätigt	Canaccord Genuity	Buy
2019-05-06	Eingeleitet	Goldman	Buy
2019-04-09	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2019-03-04	Bestätigt	Needham	Buy
2018-07-03	Bestätigt	Needham	Buy
2018-07-02	Bestätigt	Needham	Buy
2018-04-05	Herabstufung	Barclays	Overweight → Equal Weight
2018-02-22	Bestätigt	Canaccord Genuity	Buy
2017-12-15	Eingeleitet	Canaccord Genuity	Buy
2017-10-03	Bestätigt	Needham	Buy

Alle ansehen

Biohaven Ltd Aktie (BHVN) Neueste Nachrichten

Nov 02, 2025

Has Biohaven Ltd. formed a bullish divergenceEarnings Performance Report & Risk Controlled Stock Pick Alerts - newser.com

Nov 02, 2025

Will Biohaven Ltd. stock gain from government policies2025 Market Sentiment & Safe Entry Zone Tips - newser.com

Nov 02, 2025

Is a relief rally coming for Biohaven Ltd. holdersJuly 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com

Nov 02, 2025

How cyclical is Biohaven Ltd. Common Shares stock compared to rivalsJuly 2025 Summary & Comprehensive Market Scan Reports - newser.com

Nov 02, 2025

Biohaven Ltd. (NYSE:BHVN) institutional owners may be pleased with recent gains after 66% loss over the past year - Yahoo Finance

Nov 02, 2025

How Biohaven Ltd. Common Shares stock trades in high volatilityTrend Reversal & AI Forecast Swing Trade Picks - newser.com

Nov 02, 2025

Earnings visualization tools for Biohaven Ltd.2025 Buyback Activity & Stepwise Entry and Exit Trade Signals - newser.com

Nov 02, 2025

Biohaven Ltd. stock chart pattern explainedQuarterly Trade Review & Capital Efficient Trading Techniques - newser.com

Nov 02, 2025

Nov 01, 2025

Relative strength of Biohaven Ltd. in sector analysisJuly 2025 Selloffs & Short-Term High Return Strategies - newser.com

Nov 01, 2025

Is Biohaven Ltd. Common Shares stock a contrarian opportunityJuly 2025 PreEarnings & Risk Controlled Daily Plans - newser.com

Nov 01, 2025

Will Biohaven Ltd. stock remain a Wall Street favoriteEarnings Risk Summary & Weekly Top Gainers Alerts - newser.com

Nov 01, 2025

Will Biohaven Ltd. stock maintain momentum in 20252025 Retail Activity & Long-Term Growth Stock Strategies - newser.com

Nov 01, 2025

Market reaction to Biohaven Ltd.’s recent newsJuly 2025 Closing Moves & Daily Momentum Trading Reports - newser.com

Nov 01, 2025

Oct 31, 2025

Predicting Biohaven Ltd. trend using moving averagesPortfolio Growth Summary & Growth-Oriented Investment Plans - newser.com

Oct 31, 2025

Emerald Mutual Fund Advisers Trust Has $2.44 Million Stock Holdings in Biohaven Ltd. $BHVN - MarketBeat

Oct 31, 2025

Emerald Advisers LLC Sells 33,944 Shares of Biohaven Ltd. $BHVN - MarketBeat

Oct 31, 2025

Signal strength of Biohaven Ltd. stock in tech scannersTrade Analysis Report & Long-Term Safe Return Strategies - newser.com

Oct 31, 2025

Biohaven Ltd. stock trend outlook and recovery pathWeekly Investment Summary & Fast Moving Trade Plans - newser.com

Oct 31, 2025

Why retail investors pile into Biohaven Ltd. stockTrade Volume Report & Weekly Stock Breakout Alerts - newser.com

Oct 31, 2025

Oct 30, 2025

Vanguard holds 2,875,190 Biohaven shares; 2.71% of class - Stock Titan

Oct 30, 2025